aitiologic GmbH

At aitiologic, an Austrian precision medicine startup, we are aiming to enable early disease detection and targeted therapy through AI-powered innovations. Central to our mission is the development of the aitios® platform, designed specifically for tissue-specific mutation detection.

Founded in June 2023, we build on patented liquid biopsy technology originally developed at Siemens Healthineers and are working towards first applications in non-invasive prenatal testing and oncology.